Also trades as: 94E.F (FSX) · $vol 0M
ZURA NASDAQ
Zura Bio Limited
1W: +6.8%
1M: +4.2%
3M: -19.6%
YTD: -23.1%
1Y: +15.7%
3Y: -7.6%
$4.27
+0.71 (+19.94%)
Weekly Expected Move ±11.4%
$3
$3
$3
$4
$4
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$409.2M
52W Range3.25-7.44
Volume5,039,426
Avg Volume2,165,114
Beta-0.04
Dividend—
Analyst Ratings
Company Info
CEOSandeep C. Kulkarni
Employees40
SectorHealthcare
IndustryBiotechnology
IPO Date2023-03-21
Websitezurabio.com
1489 W. Warm Springs Road
Henderson, NV 89014
US
Henderson, NV 89014
US
858 247 0520
About Zura Bio Limited
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Latest News
Zura Bio GAAP EPS of -$0.21 misses by $0.02
Zura Bio GAAP EPS of -$0.22
AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Boothbay Fund Management LLC Acquires New Shares in Zura Bio Limited $ZURA
Atika Capital Management LLC Takes Position in Zura Bio Limited $ZURA
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Jarrett Jennifer | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Thiara Parvinder | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Schoch Steven J | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Nirula Ajay | A-Award | 51,000 | $3.62 | 2026-06-17 |
| Munshi Amit | A-Award | 51,000 | $3.62 | 2026-06-17 |